ELMD Stock Analysis: Buy, Sell, or Hold?
ELMD - Electromed, Inc.
$45.99
0.34 (0.74%)
▲
5d:
-0.69%
30d:
+23.7%
90d:
+90.67%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 25, 2026
Get Alerted When ELMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ELMD shows positive signals but monitor for confirmation. Market pricing in 10.8% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: ELMD shows positive signals but monitor for confirmation. Market pricing in 10.8% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$61.42
Based on 12.8% avg growth
INTRINSIC VALUE TODAY
$38.14
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ELMD is currently trading at $45.99, which is considered extended relative to its 30-day fair value range of $37.05 to $44.14. From a valuation perspective, the stock is trading at a premium (Forward PE: 31.1) compared to its historical average (22.9). At these levels, the market is pricing in 10.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ELMD is in a uptrend. The price is approaching resistance at $40.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ELMD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. However, the stock is trading significantly above the average Wall Street target of $40.33. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ELMD is in a uptrend. The price is approaching resistance at $40.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ELMD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. However, the stock is trading significantly above the average Wall Street target of $40.33. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$37.05 -
$44.14
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
60.8%
Protect Your Profits
ELMD is technically overbought (RSI 72). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 12.3% above Wall St target ($40.33)
- NEUTRAL: Trading at premium valuation - market expects 10.8% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$37.05 -
$44.14
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$3.54
(7.7%)
Support & Resistance Levels
Support Level
$35.61
Resistance Level
$40.00
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
31.07
Wall Street Target
$40.33
(-12.3%)
Revenue Growth (YoY)
18.4%
Earnings Growth (YoY)
66.7%
Profit Margin
14.1%
Valuation Premium vs History
+10.8% premium
PE vs Historical
31.1 vs 22.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+10.8%
(market-implied from PE analysis)
1-Year Target
$50.96
(+11%)
2-Year Target
$56.46
(+23%)
3-Year Target
$62.56
(+36%)
3-Yr Target (if PE normalizes)
(PE: 31→23)
PE COMPRESSION
$46.10
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 31.1, Growth: 21.6%)
$82.77
(+80%)
Base:
(SPY PE: 21.8, Growth: 21.6%)
$58.02
(+26%)
Bear:
(PE: 18.5, Growth: 21.6%)
$49.31
(+7%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (39x PE), but valuation improves significantly next year (31x PE) as earnings recover.
Trailing PE: 39.02 | Current EPS (TTM): $1.17
Bull Case
$63.52
(+38%)
Analyst growth 26.5%, PE expands to 42.9
Base Case
$57.75
(+26%)
Market implied 26.5%, PE stable at 39.0
Bear Case
$31.04
(-33%)
Severe decline -20.0%, PE contracts to 33.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 13, 2026 8:14 PM ET
Data refreshes hourly during market hours. Next update: 9:14 PM
Data refreshes hourly during market hours. Next update: 9:14 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 65 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 67 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 59 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$239 | 57 HOLD |
Advanced ELMD Option Strategies
Professional options setups generated by AI based on today's ELMD price and gamma walls.
